Iovance Biotherapeutics Correlations
IOVA Stock | USD 10.59 1.69 13.76% |
The correlation of Iovance Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Iovance Biotherapeutics Correlation With Market
Modest diversification
The correlation between Iovance Biotherapeutics and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.
Iovance |
Moving together with Iovance Stock
Moving against Iovance Stock
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Iovance Stock performing well and Iovance Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Iovance Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PTCT | 2.20 | 0.28 | 0.15 | 0.35 | 2.08 | 5.65 | 20.85 | |||
KRYS | 1.67 | (0.05) | 0.01 | 0.12 | 1.70 | 3.27 | 11.08 | |||
SRPT | 1.38 | (0.27) | 0.00 | (0.24) | 0.00 | 2.64 | 9.65 | |||
MDGL | 2.35 | 0.60 | 0.24 | 4.12 | 1.56 | 3.90 | 23.05 | |||
CVAC | 2.22 | (0.44) | 0.00 | (0.24) | 0.00 | 4.45 | 16.27 | |||
APLS | 2.09 | (0.42) | 0.00 | (0.48) | 0.00 | 4.00 | 15.97 | |||
MRTX | 2.24 | (0.37) | 0.00 | 1.30 | 0.00 | 4.02 | 16.13 | |||
CWBR | 7.34 | 2.31 | 0.32 | 2.67 | 5.34 | 5.73 | 250.97 | |||
RAIN | 4.26 | (0.58) | 0.00 | 2.33 | 0.00 | 4.89 | 98.38 |
Iovance Biotherapeutics Corporate Management
Esq JD | President, CEO | Profile | |
Igor Bilinsky | Chief Officer | Profile | |
Friedrich MD | Chief Officer | Profile | |
Howard MBA | Chief Officer | Profile | |
Kevin Smyth | Executive Quality | Profile | |
JeanMarc MBA | Chief Officer | Profile | |
Sara Pellegrino | Vice Relations | Profile |